Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components

12 Months Ended

Dec. 31, 2018

NOTE 7—BALANCE SHEET COMPONENTS

Accrued liabilities comprise the following (in thousands):

	December 31,
	2018		2017
Accrued liabilities:
General and administrative	297		$	374
Clinical trial related costs	598			702
Non-clinical research and manufacturing operations		2,644		435
Payroll related		1,787		1,149
Other accrued expenses	31			30
Total accrued liabilities	$	5,357	$	2,690

Deferred revenue was comprised of the following:

	December 31,
	2018		2017
Deferred revenue
Grant agreements	$	—	$	1,673
Research and development agreements		28,901		1,092
Total deferred revenue	$	28,901	$	2,765